Pituitary, Thyroid & Adrenal Disorders
From the Journals
GLP-1 Receptor Agonists Don’t Raise Thyroid Cancer Risk
Researchers compared data from 145,410 patients who initiated GLP-1 RAs and 291,667 patients initiating dipeptidyl peptidase 4 (DPP4) inhibitors...
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
Latest News
Do Organophosphate Esters Increase Thyroid Disease Risk?
Chemicals found in flame retardants were linked to increased risk for thyroid disease, study finds.
Latest News
Is Adrenal Fatigue a Real Condition?
“The problem is not the adrenals — it is the exposure to stress in the brain.”
From the Journals
Thyroid Disorders and Gynecologic Cancers: Is There a Link?
Women with hyperthyroidism have a lower risk for all gynecologic cancers than those without hyperthyroidism.
From the Journals
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After Surgery
The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.
Latest News
Selenium Supplementation Shows Thyroid Benefits
Systematic review suggests selenium supplements may help patients with Hashimoto thyroiditis.
Latest News
EHR Tool Enhances Primary Aldosteronism Screening in Hypertensive Patients
Use of a best-practice advisory embedded in an EHR led to increased rates of screening for PA, particularly among primary care physicians.
Latest News
Direct Measurement of T3 Is Likely Vital, Say Researchers
T3 may be an important test to identify subclinical changes in thyroid function, say researchers.
From the Journals
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
Study found women with autoimmune disease were 30% more likely to have perinatal depression. Risk was also 30% higher for the reverse scenario.
Latest News
Thyroidectomy Beneficial but Risky for Hashimoto Disease
The beneficial effect lasts up to 5 years but with a substantially higher risk for complications than initially anticipated.